Effects of Empagliflozin, One of Sglt2 Inhibitors, on Cardiovascular System in Extracorporeal Membrane Oxygenation Treated Diabetic Rats: from Gene Expression to Cardiovascular Dynamics

Project title

Empagliflozin (一種SGLT2抑制劑) 對接受葉克膜治療之糖尿病鼠的心血管影響：從基因表現到心臟血管力學之探討

Internal ID

MOST111-2314-B002-071

Principal Investigator

CHIH-HSIEN WANG

Start Date

August 1, 2022

End Date

July 31, 2023

Partner Organizations

National Science and Technology Council